Position in DXCM
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$360,996
+$3,413 QoQ
Shares Held
5,360
-5.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#629
of 966 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Fifth Third Wealth Advisors LLC holds $12,708,811 across 14 Medical Devices names. DXCM ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
9,529 | $3,000,110 | |
| 2 | ABT |
Abbott Laboratories
|
30,646 | $2,780,818 | |
| 3 | BSX |
Boston Scientific Corp
|
40,756 | $1,739,466 | |
| 4 | MDT |
Medtronic plc
|
19,936 | $1,559,593 | |
| 5 | STE |
STERIS plc
|
3,135 | $660,136 | |
| 6 | EW |
Edwards Lifesciences Corp
|
7,136 | $645,522 | |
| 7 | PEN |
Penumbra Inc
|
1,552 | $490,044 | |
| 8 | DXCM |
Dexcom Inc
This page
|
5,360 | $360,996 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,996 | 5,360 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $357,583 | 5,694 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $351,761 | 5,300 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $387,994 | 5,766 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $521,819 | 5,978 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $480,966 | 7,043 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $477,118 | 6,135 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,987,467 | 29,646 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $829,034 | 7,312 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||